Jason Mathis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jason Mathis has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Aaron M. Secrest
Department of Dermatology, University of Utah, Salt Lake City, USA
2 shared publications - Dev Ram Sahni
Department of Dermatology, University of Utah Health, Salt Lake City, Utah, USA
2 shared publications - Aishwarya Suresh
Department of Otolaryngology‐Head and Neck Surgery Loma Linda University Health Loma Linda California USA
1 shared publication - Amanda M. Walker
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
1 shared publication - Amir A. Amanullah
Department of Radiology, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
1 shared publication - Ashley M. Snyder
Department of Dermatology University of Utah Salt Lake City Utah USA
1 shared publication
Latest Publications
- Open Access
- 31 January 2023
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 34 (1) , 2171707
Granulomatous cheilitis — is there a role for allergen screening and avoidance?
Dear Editor,The purpose of this letter is to highlight the efficacy of allergen avoidance and advocate for a more sensitive method for identifying these allergic triggers, in the treatment of patie...
- 31 January 2023
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 34 (1) , 2171707
Open AccessGranulomatous cheilitis — is there a role for allergen screening and avoidance?
Dear Editor,The purpose of this letter is to highlight the efficacy of allergen avoidance and advocate for a more sensitive method for identifying these allergic triggers, in the treatment of patie...
- Open Access
- 25 March 2022
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2022, 1-3
Interstitial Granulomatous Drug Reaction to Ustekinumab
Interstitial granulomatous drug reaction (IGDR) is a distinct inflammatory process that often presents as annular, violaceous plaques distributed on the extremities, proximal trunk, and intertriginous areas. The list of drugs implicated for inciting IGDR is growing, but most prominently includes ACE inhibitors, antihistamines, beta-blockers, antidepressants, and anticonvulsants. Ustekinumab is a human monoclonal antibody that targets inflammatory cytokines IL-12 and IL-23 and has been have shown to be effective in treating IGDR. However, we present a case that suggests ustekinumab can also act as an inciting agent for IGDR.
- 25 March 2022
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2022, 1-3
Open AccessInterstitial Granulomatous Drug Reaction to Ustekinumab
Interstitial granulomatous drug reaction (IGDR) is a distinct inflammatory process that often presents as annular, violaceous plaques distributed on the extremities, proximal trunk, and intertriginous areas. The list of drugs implicated for inciting IGDR is growing, but most prominently includes ACE inhibitors, antihistamines, beta-blockers, antidepressants, and anticonvulsants. Ustekinumab is a human monoclonal antibody that targets inflammatory cytokines IL-12 and IL-23 and has been have shown to be effective in treating IGDR. However, we present a case that suggests ustekinumab can also act as an inciting agent for IGDR.
- Open Access
- 17 February 2022
- Published by Elsevier in JAAD Case Reports
- Vol. 22, 38-41
Paraneoplastic subacute cutaneous lupus erythematosus with mucositis
- 17 February 2022
- Published by Elsevier in JAAD Case Reports
- Vol. 22, 38-41
Open AccessParaneoplastic subacute cutaneous lupus erythematosus with mucositis
- 2 September 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (11) , E421
Reply: “IFN‐α and TNF‐α serum levels and their association with disease severity in Egyptian children and adults with alopecia areata”
- 2 September 2021
- Published by Wiley in International Journal of Dermatology
- Vol. 61 (11) , E421
Reply: “IFN‐α and TNF‐α serum levels and their association with disease severity in Egyptian children and adults with alopecia areata”
- 1 September 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (3) , AB10
25712 Retrospective review of IVIG use and cutaneous lupus in inflammatory autoimmune neuropathies
- 1 September 2021
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 85 (3) , AB10
25712 Retrospective review of IVIG use and cutaneous lupus in inflammatory autoimmune neuropathies